Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$870M |
| 2 |
Amazon
AMZN
|
+$319M |
| 3 |
Automatic Data Processing
ADP
|
+$216M |
| 4 |
Evergy
EVRG
|
+$214M |
| 5 |
Chevron
CVX
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$296M |
| 2 |
Mondelez International
MDLZ
|
+$235M |
| 3 |
Abbott
ABT
|
+$229M |
| 4 |
Lam Research
LRCX
|
+$189M |
| 5 |
American International
AIG
|
+$170M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.97% |
| 2 | Technology | 12.66% |
| 3 | Healthcare | 12.25% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
ProShares Short VIX Short-Term Futures ETF
SVXY
$243M
| $326K | ﹤0.01% |
+12,800
| New | +$328K |
|
|
SNR
3327
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $326K | ﹤0.01% |
43,125
-625,660
| -94% | -$4.97M |
|
|
GEN
3328
DELISTED
Genesis Healthcare, Inc.
GEN
| $326K | ﹤0.01% |
142,210
-196,468
| -58% | -$380K |
|
3329
Ascent Industries
ACNT
$134M
| $325K | ﹤0.01% |
+16,307
| New | +$297K |
|
|
LBRDA
3330
DELISTED
Liberty Broadband Class A
LBRDA
| $325K | ﹤0.01% |
4,303
-70,541
| -94% | -$5.31M |
|
3331
Costco
COST
$431B
| $324K | ﹤0.01% |
1,552
-101,254
| -98% | -$20M |
|
3332
Harvard Bioscience
HBIO
$34.4M
| $323K | ﹤0.01% |
6,035
-16,527
| -73% | -$847K |
|
3333
Kornit Digital
KRNT
$708M
| $323K | ﹤0.01% |
+18,128
| New | +$287K |
|
3334
MannKind Corp
MNKD
$1.31B
| $323K | ﹤0.01% |
170,247
-869,449
| -84% | -$1.63M |
|
|
GARS
3335
DELISTED
Garrison Capital Inc.
GARS
| $323K | ﹤0.01% |
39,705
+8,895
| +29% | +$74.6K |
|
3336
Nuveen California Quality Municipal Income Fund
NAC
$1.83B
| $322K | ﹤0.01% |
24,111
+7,100
| +42% | +$94.9K |
|
3337
Tantech Holdings
TANH
$5.23M
| $322K | ﹤0.01% |
12
| – | – |
|
|
MRUS
3338
DELISTED
Merus
MRUS
| $321K | ﹤0.01% |
14,097
-334
| -2% | -$6.24K |
|
|
ENV
3339
DELISTED
ENVESTNET, INC.
ENV
| $321K | ﹤0.01% |
5,835
-53,269
| -90% | -$2.96M |
|
|
SIGM
3340
DELISTED
Sigma Designs Inc
SIGM
| $320K | ﹤0.01% |
+52,488
| New | +$326K |
|
3341
Aptevo Therapeutics
APVO
$4.34M
| – | – |
0
| – | – |
|
|
ONCT
3342
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $318K | ﹤0.01% |
148
-723
| -83% | -$1.83M |
|
3343
MVB Financial
MVBF
$392M
| $316K | ﹤0.01% |
17,480
-83,371
| -83% | -$1.58M |
|
|
IMDX
3344
Insight Molecular Diagnostics
IMDX
$141M
| $316K | ﹤0.01% |
+6,191
| New | +$305K |
|
|
HDSN
3345
Hudson Technologies
HDSN
$232M
| $315K | ﹤0.01% |
156,723
+126,472
| +418% | +$410K |
|
3346
Neurogene
NGNE
$793M
| $315K | ﹤0.01% |
5,953
-918
| -13% | -$239K |
|
3347
Strategic Education
STRA
$1.87B
| $315K | ﹤0.01% |
2,785
-3,164
| -53% | -$338K |
|
3348
First Mid Bancshares
FMBH
$1.34B
| $314K | ﹤0.01% |
+7,988
| New | +$303K |
|
3349
CPI Card Group
PMTS
$329M
| $314K | ﹤0.01% |
156,774
+62,087
| +66% | +$160K |
|
3350
AerCap
AER
$23.2B
| $312K | ﹤0.01% |
5,771
-26,299
| -82% | -$1.42M |
|
Similar funds
Israel Englander's Q2 2018 Portfolio in Review
As of Q2 2018, Israel Englander held 4,494 positions worth $76.7B, up 2.3% from $74.9B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
Israel Englander's Q2 2018 filing shows 911 new, 1,261 increased, 1,542 reduced and 746 closed positions. Its largest new stake was Evergy: 3,989,462 shares worth $224M. The largest sale was Bank of America, an estimated $296M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2018 buy was Evergy: 3,989,462 shares worth $224M.
- Israel Englander added most to Keurig Dr Pepper in Q2 2018, an estimated $870M increase.
- Israel Englander's biggest Q2 2018 reduction was Bank of America, cutting an estimated $296M.
- Israel Englander fully exited American International in Q2 2018, selling an estimated $170M.
- Israel Englander's ten largest holdings make up 7.3% of its $76.7B portfolio in Q2 2018.
- Israel Englander opened 911 new positions and closed 746 in Q2 2018.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $76.7B.
Based on Millennium Management's 13F filing for Q2 2018, filed 14 Aug 2018.